These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20531431)

  • 1. Parkinson disease: Parkinson disease-moving beyond association.
    Ross OA; Farrer MJ
    Nat Rev Neurol; 2010 Jun; 6(6):305-7. PubMed ID: 20531431
    [No Abstract]   [Full Text] [Related]  

  • 2. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease.
    Edwards TL; Scott WK; Almonte C; Burt A; Powell EH; Beecham GW; Wang L; Züchner S; Konidari I; Wang G; Singer C; Nahab F; Scott B; Stajich JM; Pericak-Vance M; Haines J; Vance JM; Martin ER
    Ann Hum Genet; 2010 Mar; 74(2):97-109. PubMed ID: 20070850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gene for sporadic Parkinson's disease: common disease-common variants].
    Toda T; Satake W
    Rinsho Shinkeigaku; 2010 Nov; 50(11):864. PubMed ID: 21921475
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of interaction of SNCA and MAPT genotypes in Parkinson's disease.
    Botta-Orfila T; Ezquerra M; Ríos J; Fernández-Santiago R; Cervantes S; Samaranch L; Pastor P; Martí MJ; Muñoz E; Valldeoriola F; Aguilar M; Calopa M; Hernández-Vara J; Tolosa E
    Eur J Neurol; 2011 Mar; 18(3):e32. PubMed ID: 21054681
    [No Abstract]   [Full Text] [Related]  

  • 5. Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.
    Davis AA; Andruska KM; Benitez BA; Racette BA; Perlmutter JS; Cruchaga C
    Neurobiol Aging; 2016 Jan; 37():209.e1-209.e7. PubMed ID: 26601739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between α-synuclein and tau genotypes and the progression of Parkinson's disease.
    Huang Y; Rowe DB; Halliday GM
    J Parkinsons Dis; 2011; 1(3):271-6. PubMed ID: 23939307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying genes in Parkinson disease: state of the art.
    Chew EG; Foo JN; Tan EK
    Med J Aust; 2018 May; 208(9):381-382. PubMed ID: 29764346
    [No Abstract]   [Full Text] [Related]  

  • 8. Genome-wide association study confirms extant PD risk loci among the Dutch.
    Simón-Sánchez J; van Hilten JJ; van de Warrenburg B; Post B; Berendse HW; Arepalli S; Hernandez DG; de Bie RM; Velseboer D; Scheffer H; Bloem B; van Dijk KD; Rivadeneira F; Hofman A; Uitterlinden AG; Rizzu P; Bochdanovits Z; Singleton AB; Heutink P
    Eur J Hum Genet; 2011 Jun; 19(6):655-61. PubMed ID: 21248740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of pathways to Parkinson disease.
    Hardy J
    Neuron; 2010 Oct; 68(2):201-6. PubMed ID: 20955928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study.
    Wider C; Vilariño-Güell C; Heckman MG; Jasinska-Myga B; Ortolaza-Soto AI; Diehl NN; Crook JE; Cobb SA; Bacon JA; Aasly JO; Gibson JM; Lynch T; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
    Eur J Neurol; 2011 Jun; 18(6):876-81. PubMed ID: 21159074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease.
    Goris A; Williams-Gray CH; Clark GR; Foltynie T; Lewis SJ; Brown J; Ban M; Spillantini MG; Compston A; Burn DJ; Chinnery PF; Barker RA; Sawcer SJ
    Ann Neurol; 2007 Aug; 62(2):145-53. PubMed ID: 17683088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-synuclein abnormalities trigger focal tau pathology, spreading to various brain areas in Parkinson disease.
    Hadi F; Akrami H; Totonchi M; Barzegar A; Nabavi SM; Shahpasand K
    J Neurochem; 2021 May; 157(3):727-751. PubMed ID: 33264426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Synuclein modulates tau spreading in mouse brains.
    Bassil F; Meymand ES; Brown HJ; Xu H; Cox TO; Pattabhiraman S; Maghames CM; Wu Q; Zhang B; Trojanowski JQ; Lee VM
    J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33091110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.
    Heckman MG; Elbaz A; Soto-Ortolaza AI; Serie DJ; Aasly JO; Annesi G; Auburger G; Bacon JA; Boczarska-Jedynak M; Bozi M; Brighina L; Chartier-Harlin MC; Dardiotis E; Destée A; Ferrarese C; Ferraris A; Fiske B; Gispert S; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lin CH; Lohmann K; Loriot MA; Lynch T; Mellick GD; Mutez E; Opala G; Park SS; Petrucci S; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Tomiyama H; Uitti RJ; Valente EM; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Xiromerisiou G; Maraganore DM; Farrer MJ; Ross OA;
    Neurobiol Aging; 2014 Jan; 35(1):266.e5-14. PubMed ID: 23962496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease.
    Roy B; Jackson GR
    Hum Mol Genet; 2014 Jun; 23(11):3008-23. PubMed ID: 24430504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic susceptibility in Parkinson's disease.
    Bras JM; Singleton A
    Biochim Biophys Acta; 2009 Jul; 1792(7):597-603. PubMed ID: 19063963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population.
    Trotta L; Guella I; Soldà G; Sironi F; Tesei S; Canesi M; Pezzoli G; Goldwurm S; Duga S; Asselta R
    Parkinsonism Relat Disord; 2012 Mar; 18(3):257-62. PubMed ID: 22104010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NEURODEGENERATION. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein.
    Goedert M
    Science; 2015 Aug; 349(6248):1255555. PubMed ID: 26250687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease.
    Mata IF; Yearout D; Alvarez V; Coto E; de Mena L; Ribacoba R; Lorenzo-Betancor O; Samaranch L; Pastor P; Cervantes S; Infante J; Garcia-Gorostiaga I; Sierra M; Combarros O; Snapinn KW; Edwards KL; Zabetian CP
    Mov Disord; 2011 Apr; 26(5):819-23. PubMed ID: 21425343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of GWAS associations for GAK and MAPT in Parkinson's disease.
    Rhodes SL; Sinsheimer JS; Bordelon Y; Bronstein JM; Ritz B
    Ann Hum Genet; 2011 Mar; 75(2):195-200. PubMed ID: 21058943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.